top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Teva names Richard Francis as CEO

Tel Aviv, Israel, November 21, 2023 (Reuters) -- Teva Pharmaceutical (TEVA.TA) has named Richard Francis, former executive at Novartis (NOVN.S) and Biogen (BIIB.O), as the successor to CEO Kare Schultz, set to retire later this year. Currently leading gene therapy firm Purespring Therapeutics and biopharma company Forcefield Therapeutics, Francis will assume the position of Teva's president, starting Jan. 1, 2023.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines

© 2024 by Jacobs Management Group, Inc.

​

Privacy Policy

​

bottom of page